$BSX is down substantially on FDA issues and competitors $MDT and $STJ have spiked up. These are minor paperwork issues and will not have a long term impact. Scale in on $BSX on dips. Scale in on $MDT and $STJ on spikes.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER